APPOINTMENT OF DESIGNATED DEPOSITORY FOR THE PURPOSE OF SYSTEM DRIVEN DISCLOSURE IN SECURITIES MARKET
APPOINTMENT OF DESIGNATED DEPOSITORY FOR THE PURPOSE OF SYSTEM DRIVEN DISCLOSURE IN SECURITIES MARKET06-07-2018
06-07-2018
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
Disclosure under regulation 30 of the SEBI (LODR) Regulations, 201525-06-2018
Will GMP certificate revive Orchid Pharma?
Orchid Pharma, which is currently under the corporate insolvency resolution process, has received the European Union GMP (Good Manufacturing Practice)11-06-2018
ORCHID HAS RECEIVED EU GMP(GOOD MANUFACTURING PRACTICE) CERTIFICATION
ORCHID HAS RECEIVED EU GMP(GOOD MANUFACTURING PRACTICE) CERTIFICATION11-06-2018
DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LODR) REGULATIONS,2015
DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LODR) REGULATIONS,201514-05-2018
CERTIFICATE UNDER REGULATION 40(9) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS,2015
CERTIFICATE UNDER REGULATION 40(9) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS,201523-04-2018
Shareholding for the Period Ended March 31, 2018
Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here21-04-2018
Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- L CHANDRASEKARDesignation :- Company Secretary and Compliance Officer19-04-2018